文献速递免疫规划妇幼与学校卫生

利用真实世界数据评估孕期接种疫苗儿科安全性与有效性的方法学范围综述

Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
PubMed 文献 · Vaccine · 2021-06-02

本范围综述梳理了使用真实世界数据(RWD)评估孕期接种灭活流感疫苗和破伤风-白喉-无细胞百日咳联合疫苗(Tdap)后婴儿安全性与有效性的研究。结论认为现有文献可为未来研究设计提供基础,尤其对未纳入孕妇临床试验的新疫苗至关重要。

要点

  • 多数研究未详细报告数据来源、母婴数据链接及孕龄操作定义。
  • 现有文献可为未来孕期疫苗接种RWD研究设计提供知识基础。

核心结论

  • 现有文献可用于规划与设计未来使用RWD的孕期疫苗接种研究。
  • 多数研究缺乏方法学细节,引发对可重复性和有效性的担忧。

研究设计与样本

  • 范围综述,遵循已发表方案,检索PubMed和Embase,双人筛选与数据提取。
  • 纳入报告孕妇及其婴儿有效性或安全性结局的研究。

主要发现

  • 多数研究缺乏数据来源、母婴数据链接及孕龄操作定义的详细信息。

关键数值与推荐

  • 美国推荐所有孕妇接种灭活流感疫苗(自2004年起)和Tdap疫苗(自2013年起)以预防婴儿疾病。

临床怎么用

  • 开展孕期疫苗接种RWD研究时,应详细报告数据来源、母婴数据链接方法及孕龄操作定义。
  • 未来研究设计可参考现有文献,但需注意方法学质量差异。

局限性

  • 多数纳入研究缺乏方法学细节,影响结果的可重复性和有效性评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This scoping review mapped studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women. INTRODUCTION: In the US, two vaccines are recommended for all pregnant women to prevent illness in the infant: inactivated influenza vaccine (recommended since 2004), and the combined tetanus-diphtheria-acellular pertussis (Tdap) vaccine (recommended since 2013). This scoping review maps the studies conducted to date that address questions about pediatric safety and effectiveness of vaccines administered during pregnancy and provides a knowledge base for evaluating the use of RWD to study this issue. METHODS: The scoping review was conducted following a published protocol. Methods included an electronic search of PubMed and Embase, screening of titles and abstracts by two reviewers, and double extraction of data for summary and synthesis. Studies that reported on pregnant women and the effectiveness or safety outcomes in their infants were included. RESULTS: Forty-eight studies met the inclusion criteria of the scoping review protocol using RWD to assess safety or effectiveness of influenza or pertussis vaccinations administered to pregnant women with respect to pregnancy, infant or child outcomes. Detailed information about data sources, linkage of maternal and infant data, and operational definitions for gestational age were largely absent from the majority of studies raising concerns about reproducibility and validity of study findings. CONCLUSIONS: A body of literature is available from which to plan and design future studies of vaccination in pregnant women using RWD. This is of intense importance as new vaccines, such as those for COVID-19, become available to the general population via approval or authorization without inclusion of pregnant women in the clinical trials.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lasky T, McMahon AW, Hua W, et al. Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review. Vaccine. 2021. PMID: 34090699. doi:10.1016/j.vaccine.2021.05.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。